Prototype success doesn’t guarantee production success.

What OEMs Need to Know Before Scaling Robotic Surgical Systems

Early builds can prove that a design works. Getting from there to validated, repeatable production is where most programs run into trouble.

This white paper explores the manufacturing realities OEMs face as robotic-assisted surgery systems move toward commercial launch, from tolerance stack-up and DFM engagement to process validation and partner selection. Vantedge Medical's Blake Forsberg, Senior Manager of NPI Programs, and Cassandra Haupers, Senior Director of Strategic Accounts, share a practical look at what separates programs that scale cleanly from those that don't.

What You'll Learn

• Why tolerance stack-up problems tend to surface at predictable stages, and what to do before they do
• How early DFM engagement reduces costly redesigns and improves long-term production stability
• What process validation actually requires when you're preparing a surgical robotics program for scale
• How to evaluate whether a manufacturing partner can grow alongside your product
• What high-performing OEM programs do differently from prototype through production